Abstract: A compound has a formula (I) R1-Wm-Xn-AA1-AA2-AA3-AA4-AA5-AA6-(AA7)a-(AA8)b-Yp-Zq-R2, its stereoisomers and/or its cosmetically or pharmaceutically acceptable salts, wherein: AA1 is Glu or replaced by Asp, Gln or Asn, AA2 is Glu or replaced by Asp or Gln; AA3 is Met or replaced by Leu or Ile; AA4 is Gln or replaced by Glu, Asn or Asp; AA5 is Arg or replaced by Lys; AA6 is Arg or replaced by Lys or His; AA7 is Ala, Ser, Gly, Thr, Pro, Glu, Lys, or Val; AA8 is Asp, Glu, Asn, or Gln. In the compound, no more than two of AA1, AA2, AA3, AA4, AA5 and AA6 are replaced, a and b are 0 or 1; W, X, Y and Z are amino acids; m, n, p and q are each 0 or 1; and R1 and R2 are not amino acids. A method of skin treatment with the compound is also described.

Abstract: A ferment extract from a bacterial strain the Eupenicillium crustaceum species useful in the cosmetic treatment and/or care of the skin, mucous membranes, hair and/or nails and cosmetic uses of same.

Abstract: Exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for inflammation, lipolysis, lipid accumulation and skin firmness.

Abstract: A method of treatment and/or care of the skin includes administering a composition which includes a cosmetically or dermopharmaceutically effective quantity (between 0.000001% by weight and 5% by weight of the composition) of an exopolysaccharide produced by a strain of Halomonas eurihalina, or a ferment extract comprising the exopolysaccharide. The exopolysaccharide has a composition by weight of 0.5% to 45% of rhamnose, 0.1% to 25% of galactose, 0.5% to 30% of mannose, 50% to 95% for the sum of glucose and D-glucosamine, 0% to 10% of fucose and 0% to 12% of glucuronic acid, with the condition that the sum of the percentages does not exceed 100%.

Abstract: A ferment extract of a bacterial strain of the Bacillus pumilus species, a method of treatment and/or care of the skin and/or muscles, and cosmetic and/or dermopharmaceutical compositions containing the ferment extract. In particular, the ferment extract is used for muscular endurance, wound healing and skin firmness.

Abstract: A ferment extract from a bacterial strain the Eupenicillium crustaceum species useful in the cosmetic treatment and/or care of the skin, mucous membranes, hair and/or nails and cosmetic uses of same.

Abstract: Ferment extract and exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for skin aging, skin firmness and hydration.

Abstract: A cosmetic or pharmaceutical method for the treatment and/or care of the skin and/or hair which includes administering to the skin and/or hair an effective amount of at least one peptide of general formula (I): R1-AA1-AA2-AA3-R2?? (I) where AA1 and AA2 are independently selected from -Tyr- and -Phe- and AA3 is selected from -Nle- and -Met-, its stereoisomers, mixtures thereof and/or cosmetically or pharmaceutically acceptable salts thereof, in the treatment and/or care of conditions, disorders and/or diseases of the skin and/or hair by stimulating cyclic adenosine monophosphate synthesis (cAMP).

Abstract: A ferment extract of a bacterial strain of the Bacillus pumilus species, a method of treatment and/or care of the skin and/or muscles, and cosmetic and/or dermopharmaceutical compositions containing the ferment extract. In particular, the ferment extract is used for muscular endurance, wound healing and skin firmness.

Abstract: Exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for inflammation, lipolysis, lipid accumulation and skin firmness.

Abstract: Peptides of general formula (I): R1AA1-AA2-AA3-AA4-R2 stereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.

Abstract: Cosmetic or pharmaceutical compositions and methods employ peptides of general formula (I): R1-AA1-AA2-AA3-R2,??(I) where AA1 is selected from -Tyr- and -Phe-, AA2 is -Tyr-, and AA3 is selected from -Nle- and -Met-, its stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, in the treatment and/or care of conditions, disorders and/or diseases of the skin and/or hair by stimulating cyclic adenosine monophosphate synthesis (cAMP).

Abstract: Peptides of general formula (I): R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zs-R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, their preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases that are a consequence of muscle contraction.

Abstract: Peptides of general formula (I): R1-Wp-Xn-AA1-AA2-AA3-AA4-Ym-R2 their stereoisomers, mixtures thereof, and/or their cosmetically or pharmaceutically acceptable salts, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment, prevention and/or care of conditions, disorders and/or diseases of the skin, mucous membranes and/or scalp.

Abstract: Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zs—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, their preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases that are a consequence of muscle contraction.

Abstract: Peptides of general formula (I): R1-AA1-AA2-AA3-R2??(I) its stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases of the skin and/or hair.

Abstract: Peptides of general formula (I): R1-Wp-Xn-AA1-AA2-AA3-AA4-Ym-R2 their stereoisomers, mixtures thereof, and/or their cosmetically or pharmaceutically acceptable salts, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment, prevention and/or care of conditions, disorders and/or diseases of the skin, mucous membranes and/or scalp.

Abstract: Peptides of general formula (I): R1AA1-AA2-AA3-AA4-R2 stereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.